pulmonary medicine

ORLANDO, Fla., May 19, 2026 Savara presented new long-term efficacy and safety data from the ongoing IMPALA-2 Phase 3...

ORLANDO, Fla., May 19, 2026 Altesa BioSciences announced positive results from its randomized, placebo-controlled Phase 2 rhinovirus challenge study...